A detailed history of Public Employees Retirement System Of Ohio transactions in Regenxbio Inc. stock. As of the latest transaction made, Public Employees Retirement System Of Ohio holds 13,973 shares of RGNX stock, worth $119,329. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,973
Previous 13,973 -0.0%
Holding current value
$119,329
Previous $163,000 10.43%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$11.51 - $21.53 $9,737 - $18,214
-846 Reduced 5.71%
13,973 $163,000
Q1 2024

May 15, 2024

SELL
$12.17 - $24.61 $524,928 - $1.06 Million
-43,133 Reduced 74.43%
14,819 $312,000
Q4 2023

Feb 15, 2024

BUY
$12.89 - $20.82 $363,317 - $586,832
28,186 Added 94.69%
57,952 $1.04 Million
Q1 2023

Dec 19, 2023

BUY
$18.08 - $24.55 $443,411 - $602,088
24,525 Added 467.95%
29,766 $562,000
Q1 2023

May 15, 2023

BUY
$18.08 - $24.55 $443,411 - $602,088
24,525 Added 467.95%
29,766 $563,000
Q4 2022

Dec 19, 2023

SELL
$20.4 - $24.73 $500,309 - $606,503
-24,525 Reduced 82.39%
5,241 $118,000
Q4 2022

Feb 15, 2023

BUY
$20.4 - $24.73 $38,148 - $46,245
1,870 Added 55.47%
5,241 $119,000
Q3 2022

Nov 15, 2022

SELL
$22.29 - $35.04 $175,199 - $275,414
-7,860 Reduced 69.98%
3,371 $89,000
Q2 2022

Aug 15, 2022

SELL
$19.35 - $35.04 $86,126 - $155,963
-4,451 Reduced 28.38%
11,231 $277,000
Q1 2022

May 16, 2022

BUY
$24.62 - $34.31 $386,090 - $538,049
15,682 New
15,682 $520,000
Q2 2019

Aug 12, 2019

SELL
$42.0 - $59.29 $476,784 - $673,060
-11,352 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$40.82 - $62.45 $244,430 - $373,950
5,988 Added 111.63%
11,352 $651,000
Q4 2018

Feb 15, 2019

BUY
$39.11 - $75.15 $15,565 - $29,909
398 Added 8.01%
5,364 $225,000
Q3 2018

Nov 14, 2018

BUY
$65.0 - $82.15 $322,790 - $407,956
4,966 New
4,966 $375,000

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $369M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Public Employees Retirement System Of Ohio Portfolio

Follow Public Employees Retirement System Of Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.